dabrafenib

Italy

Drugs containing this active substance

  • FINLEE

    It is used in children over 1 year of age to treat a type of brain tumor called glioma, in combination with another medicine (trametinib). The treatment is indicated for patients with a specific BRAF gene mutation.

    Form: tablets, dispersible

    Active substance Dosage
    dabrafenib -

    ATC: L01EC02

    Manufacturer: NOVARTIS EUROPHARM LIMITED

  • TAFINLAR

    It is used to treat a type of skin cancer called melanoma that has spread to other parts of the body or cannot be surgically removed. In combination with trametinib, it is also used to prevent the recurrence of melanoma after surgery and to treat a type of non-small cell lung cancer (NSCLC), provided that a specific BRAF gene mutation is present.

    Form: capsules, hard gelatin

    Active substance Dosage
    dabrafenib -

    ATC: L01EC02

    Manufacturer: NOVARTIS EUROPHARM LIMITED